Commonly recommended aspirin is given to prevent irritation to the stomach.

Do you think dentists should do A1c tests for patients with periodontal disease, especially before surgery, then report the results to their patient's primary care doctor? Follow the link to share your opinion!

The United Kingdom Prospective Diabetes Study early results data suggested metformin conferred greater cardiovascular benefits to the overweight diabetes participants than dietary interventions alone. All of the following were observed for the metformin group EXCEPT: A. A relative risk reduction for myocardial infarction of 39%. B. A relative risk reduction for all-cause mortality of 36%. C. A relative risk reduction for diabetes related death of 42%. D. An overall mean A1c reduction of 1.5%. Did you get it right? Follow the link to find out!

Woman, 53 years of age, type 1 diabetes, has been wearing an insulin pump for 18 years. Recently changed insulin pumps. Not only upgraded on a certain brand, but now has a totally different brand. We did not change settings when she started with her new pump. She called to let me know her glucose levels were higher since she has her new pump.

In this week's Homerun Slides, the implications for practice and conclusion of the EMPA-REG Outcome Trial.

PI-3 kinase-independent pathways for stimulation of glucose transport: The CAP/Cbl/TC10 pathway. Substantial evidence confirms the presence of PI-3 kinase independent pathways for stimulation of glucose transport. It had long been clear that other growth factor receptors (i.e., the platelet-derived growth factor (PDGF) receptor, cytokine receptors such as IL-4, and certain integrins) activate PI-3 kinase to the same extent as the insulin receptor with generation of PI(3,4,5)P3, yet still do not stimulate glucose transport.

For a newly diagnosed type 2 patient with an elevated A1c of 7-8%, would you consider an SGLT-2 drug as a second treatment option added to metformin if they are not at goal on metformin? Follow the link to share your opinion and see what your colleagues think!

New research finds issue in the setting of dehydration and/or during use of nonsteroidal anti-inflammatory agents (NSAIDs) or radiocontrast studies.

Investigation supports that early diabetes has lower thromboembolic risk than later.

Survey estimates that diabetes accounts for many more deaths in the United States than are being reported on death certificates — and that diabetes is actually the third leading cause of death.